"TBSF" Human Immunoglobulin for Intravenous Use

Страна: Австралия

Език: английски

Източник: Department of Health (Therapeutic Goods Administration)

Активна съставка:

normal immunoglobulin, Quantity: 60 g/L

Предлага се от:

CSL Behring Australia Pty Ltd

INN (Международно Name):

normal immunoglobulin

Лекарствена форма:

Injection, solution

Композиция:

Excipient Ingredients: maltose

Начин на приложение:

Intravenous

Броя в опаковка:

50mL, 200mL

Клас:

Medicine Listed (Export Only)

Вид предписание :

(S1) This Schedule is intentionally blank

Терапевтични показания:

TBSF Human Immunoglobulin for Intravenous Use is indicated for replacement IgG therapy in: * primary immunodeficiency (PID) * symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment. TBSF Human Immunoglobulin for Intravenous Use is indicated for immunomodulatory therapy in: * Idiopathic Thrombocytopenic Purpura (ITP), in adults or children at high risk of bleeding or prior to surgery to correct the platelet count * allogeneic bone marrow transplantation * Kawasaki disease * Guillain-Barre Syndrome (GBS).

Каталог на резюме:

Visual Identification: Clear, colourless solution; Container Type: Vial; Container Life Time: 3 Years; Container Temperature: Store at 2 to 8 degrees Celsius

Статус Оторизация:

Listed (Export Only)

Дата Оторизация:

2006-03-01